Several Northeast Ohio Med Spas Get Blasted by Ohio Attorney General

April 17, 2025

Ohio Attorney General Dave Yost announced Wednesday he sent letters to 14 medical spas, many in Northeast Ohio, warning them to stop making false or misleading claims about their versions of popular weight-loss drugs.

With the popularity of FDA approved drugs such as Ozempic, Wegovy, Zepbound and Mounjaro, several health spas are offering compounds of the active ingredient in those drugs to customers.

According to Yost, compound drugs like semaglutide and/or tirzepatide have not been tested and approved by the FDA, and some spas are advertising them as just as safe and effective.

Read more at Cleveland 19 News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • CGI Digital Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Kentucky Rules Do Not Allow Compounding of Six Peptides Despite HHS Peptide Enforcement Policy
    • AMA Urges HHS to Withdraw Proposal Expanding Access to Certain Unapproved Peptides
    • Health Canada Warns Against Unauthorized Peptides After Bacteria Found in Seized Products
    • Injectable PDGF Enters New Aesthetic Trials for Facial Skin Quality and Infraorbital Hollows